What's behind DaVita's latest 6.4% stock pullback?

Traders Union
All News
Stocks
Davita slides 6.43% today

Highlights

DaVita will release third-quarter 2026 results and hold its investor conference call on October 29, 2026.
A new US Kidney Care National Plan and recent class action settlement over an April 2025 ransomware attack may affect DaVita’s operations.
Shares of DaVita trade below short- and medium-term moving averages with a forecasted range of $161.15 to $179.85 and consolidation expected.

Investor call and legal settlement add to operating uncertainty after policy shift

DaVita scheduled its third-quarter 2026 investor conference call for October 29, 2026, with results to be released after market close. On October 20, 2026, the U.S. Department of Health and Human Services announced a new Kidney Care National Plan, which may affect DaVita's operating environment. The company also agreed to a class action lawsuit settlement related to a ransomware attack in April 2025 that exposed patient and customer data, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees the recent 6.43% decline in DaVita as a warning signal. Regulatory threats and unresolved cybersecurity risks have amplified downside sentiment. Technical pressure from trading below both the 20-day and 50-day moving averages highlights a short- to medium-term bearish bias. The overbought signals in the Stochastic RSI and CCI suggest a possible exhaustion of recent buyer strength. "Concerns about changing government policy and security setbacks mean traders should remain cautious and prepare for further weakness in DaVita’s stock," Kharitonov states.

Viktoras Karapetjanc, expert at Traders Union, believes DaVita’s pullback is a short-term market overreaction. He notes strong revenue trends and an upcoming earnings catalyst, with the long-term structure still bullish above the 200-day moving average at $173.73. Regulatory changes and the settlement show DaVita’s adaptability to adversity, while sector reforms could offer future growth opportunities. "With bullish structure intact and more macro catalysts ahead, I expect DaVita to rebound and present attractive setups for growth-focused investors," Karapetjanc states.

Parshwa Turakhiya, analyst, highlights mixed sentiment and volatility following DaVita’s recent drop. He points out that momentum remains positive despite a weak close, with oscillators indicating both overbought conditions and ongoing buyer interest. Short-term traders may find opportunity in the forecasted consolidation range, noting that breakout and breakdown scenarios remain equally viable. "I see sentiment-driven setups on both sides — nimble strategies around $173.73 support and $179.85 resistance could be key in the coming sessions," Turakhiya advises.

Mixed momentum as overbought signals clash with renewed downward pressure

DaVita is trading below its 20-day and 50-day moving averages, at $180.13 and $180.55, and above the 200-day moving average at $173.73. This positioning suggests short- and medium-term pressure from sellers, with longer-term structure remaining bullish. The nearest support is at $173.73, while resistance is seen at $179.85. The Ichimoku Kijun at $184.97 confirms overhead trend resistance. Momentum indicators present a mixed picture: the MACD and ADX signal a neutral to weakening trend. The RSI registers 57.16, pointing to ongoing buying momentum, but the Stochastic RSI and CCI both read overbought. BBP at 6.02 shows buyers dominating intraday sentiment, also flagged as overbought. The AO signals a positive trend. The stock fell $12.04 or 6.43% after an upside gap of 0.73%, opening higher and closing near the session's low, with intraday volatility at 10.13%. The pullback and weak close point to profit-taking and renewed pressure after the gap, contrasting with mostly bullish momentum readings.

Earlier, analysts noted that DaVita was experiencing short- and medium-term downside pressure despite maintaining a longer-term bullish structure. The latest developments—regulatory challenges and data breach settlement—reinforce the need to monitor $161.15 as a critical support, with the prevailing scenario now favoring near-term consolidation within the projected trading band.

Source of Data: DVA Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.